Navigation Links
Richard W. Schulte of Wright & Schulte LLC: a Tireless Fighter for Victims of Generic Drug Labeling Practices

Dayton, OH (PRWEB) April 18, 2013

Richard W. Schulte, a partner with the experienced drug injury firm of Wright & Schulte LLC, continues his fight on behalf of victims of generic drug injuries, the Firm reports. On March 14th, the Sixth Circuit Court of Appeals ruled that a woman being represented by Richard Schulte could proceed with her state failure to warn claim against Pliva, Inc. for injuries she allegedly suffered due to the company’s generic version of the drug metoclopramide. According to Wright & Schulte, numerous courts have dismissed state law failure to warn claims filed against generic drug makers, following the U.S. Supreme Court’s 2011 decision in Pliva vs. Mensing, which found that such claims were pre-empted by federal law. (Pliva, Inc. v. Mensing 131 S. Ct. 2567) The recent Sixth Circuit decision in the generic metoclopromide case creates a narrow exception to the pre-emption defense established by the Mensing decision. (Fulgenzi v. Pliva, Inc. Case No. 12 - 3504, 6th Cir.)

According to the Sixth Circuit ruling, the client represented by Richard Schulte allegedly suffered tardive dyskinesia, a repetitive movement disorder, as a result of using Pliva’s metoclopromide between 2004 and 2007 to treat her gastric reflux. In 2004, the U.S. Food & Drug Administration (FDA) ordered the maker of Reglan, the name-brand version of metoclopramide, to update the drug’s label to warn that it should not be used for longer than 12 weeks because of its association with tardive dyskinesia. However, Pliva did not follow suit and update the label of its generic metoclopramide to include the same warning.

While the generic metoclopramide lawsuit was filed before the U.S. Supreme Court issued its ruling in Pliva vs. Mensing, the claim was dismissed by a lower court in the wake of that decision. In an appeal to the Sixth Circuit, Richard Schulte of Wrigth & Schulte LLC argued that according to the federal rule of sameness, Pliva was obligated to update the warning label of the generic drug once the label on the brand name version was modified. In a unanimous decision, a three-judge panel of the Sixth Circuit agreed, finding that the company could have updated its label without violating its duty of sameness. According to Wright & Schulte, the Sixth Circuit ruling means that generic drug makers can no longer simply rely on the Mensing decision’s preemption defense to avoid liability for injuries allegedly caused by one of their products, but must be able to show they were diligent and timely in keeping their labels up-to-date.

This is not the first time Richard Schulte has taken up the fight on behalf of individuals allegedly injured by generic drugs. As Co-Lead Counsel in a multidistrict litigation underway in U.S. District Court, Eastern District of Kentucky, he is currently representing hundreds of people allegedly injured by the drug Propoxyphene, sold generically and under the brand names Darvon and Darvocet. On February 20th, Richard Schulte, together with his Co-Lead Counsel and the Center for Constitutional Litigation, filed an Amicus Brief in an important generic drug case known as Mutual Pharmaceutical Co. v. Bartlett that is currently before the U.S. Supreme Court. The Brief, which was filed on behalf of all persons allegedly injured by Propoxyphene, urged the High Court to uphold a lower court ruling allowing a jury award levied against a generic drug maker in a state law design defect claim to stand. According to the Brief, the Supreme Court’s ultimate decision in the Bartlett case will directly affect generic drug claims pending in the federal Propoxyphene litigation. (Mutual Pharmaceutical Co. v. Bartlett, 12-142.)

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced drug injury law firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free drug injury lawsuit evaluations are available through, or call 1-800-399-0795.

Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Author, Speaker Richard London Battles Parkinson’s with an Active Lifestyle and the Desire to Give Back
2. ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton Medal
3. LA BioMeds Dr. Richard Casaburi investigates causes of COPD
4. Richard Mayeux, M.D., M.S., elected Fellow of AAAS
5. Stealth Attraction: Review of Richard La Ruina's Attraction Training Course Released By
6. Jacksonville Periodontist, Dr. Richard E. Aguila, Now Fixes High Gum Lines with Crown Lengthening Procedures for His Florida Patients with Excessive Gums Showing
7. Skechers Injury Lawsuit Update: Richard W. Schulte, Partner with Wright & Schulte LLC, Appointed to Plaintiffs’ Steering Committee in California Skechers Toning Shoes Litigation
8. Ms. Viola Richardson, Jersey City Councilwoman-at-Large, Participates in the Annual Steve Sobel SYC 2013 Fencing Competition
9. Wright & Schulte LLC Encourages Drivers to Review Safe Winter Driving Tips
10. Wright & Schulte File Skechers Lawsuit on Behalf of Ohio Woman Who Fell, Suffered Broken Wrist Allegedly Due to Use of Skechers Shape-Ups
11. Wright & Schulte LLC Files Transvaginal Mesh Lawsuit on Behalf of Woman Allegedly Injured by Align Urethral Support System
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: